Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Diet Doc Medical Weight Loss Plans Issues New Advice For Patients Looking to Avoid Long Term Health Risks Associated With New FDA Approved Diet Pills
  • USA - English


News provided by

Dietdoc.co

Aug 29, 2013, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Diet Doc is the nation's leader for natural weight loss plans, offering the most comprehensive and successful collection of prescription and non-prescription diet products and services.
Diet Doc is the nation's leader for natural weight loss plans, offering the most comprehensive and successful collection of prescription and non-prescription diet products and services.

Before resorting to experimental diet drugs, over the counter diet pills, starvation diets, or even weight loss surgery, call today to schedule a free and confidential consultation.

Post this

Miami, FL (PRWEB) August 29, 2013 -- Controversy surrounding two new diet drugs, Belviq (lorcaserin) and Qsymia (phentermine plus topiramate), is at the forefront of medical headlines and dieters are urged to evaluate the benefits versus the potential health risks when making the decision to use these diet aids. Although recently approved for use in the United States, As Medical News Today reports on August 24th of this year, Europe considers these diet drugs too harmful to be marketed. Dr. Sidney Wolfe, founder of the health research group at Public Citizen, states that, after clinical trials, these drugs were approved in America despite vast cardiovascular concerns. During trials, patients were observed to have increases in pulse of more than 10 beats per minute, which is a significant risk factor for cardiovascular disease, as well as potential arrhythmia related concerns, impaired memory and reduced concentration. The diet drugs were also associated with a 16% increase in heart valve damage.

Committed to providing the safest and most successful long term weight loss solution for all patients, Diet Doc urges all Americans to be well informed and knowledgeable about drugs that are represented to promote quick weight loss. Benefiting from decades of scientific research, the company has designed prescription diet plans that are aimed toward promoting quick weight loss for patients; however, each diet is supervised by a staff of board certified doctors and nurses with diet plans specifically designed for each patient by certified nutritionists. Before experimenting with new prescription diet aids or over-the-counter diet pills, the professional weight loss staff at Diet Doc urges everyone to consider the long term health risks that these potentially dangerous drugs may induce.

Because the professionals at Diet Doc focus on patient safety first, all potential patients must complete a detailed medical evaluation followed by a consultation with an in-house physician prior to being approved for the company’s prescription weight loss program. Based on information obtained during the consultation, certified nutritionists who are educated in the science of healthy and quick weight loss design individualized diet plans that are specific to each patient’s personal needs. Diet plans are tailored for those struggling to take off that last difficult 10 pounds to those that must lose 100 pounds or more. These customized diet plans are designed to fit comfortably into the patient’s lifestyle, as well as being compatible with any existing medical conditions.

Diet Doc also now offers their clients specially formulated diet pills often featured on television as miracle fat burning supplements. One of the more popular diet aids is saffron extract, which curbs the appetite and works on emotional eating. Television doctors state that saffron extract is a breakthrough in natural weight loss pills because until now, there hasn't been an effective medication that dealt with emotional eating. This information, coming from well-respected doctors is supported by patients who report rapidly losing inches from their waistline while experiencing a significant decrease in their appetite.

By developing prescription diet aids within their own U.S. pharmacies, Diet Doc can ensure that only the highest quality ingredients are used and especially that the company’s patients are receiving only the best diet products available on the market, free from hazardous side effects. Patients will receive a one-year prescription and can order their supplements over the phone or the Internet. For added convenience, all supplements will be shipped directly to the patient’s home avoiding embarrassing or time consuming visits to local weight loss clinics. Included in their package, patients will receive a Certificate of Analysis, performed by a third party laboratory, detailing the quality of the ingredients and levels of each active ingredient.

The professionals at Diet Doc are passionate about helping people reduce their weight to avoid certain diseases and health conditions associated with being overweight. The company’s mission is to help people lose weight, offering education on what specific foods will generate a weight loss reaction in their body in order to keep the weight off long term and to provide the most effective, safest and successful weight loss experience for each patient.

Before resorting to experimental diet drugs, over the counter diet pills, starvation diets, or even weight loss surgery, call today to schedule a free and confidential consultation and join the thousands who have made Diet Doc's prescription diet plans the safest, most sensible and successful solution for unwanted and unhealthy excess fat.

Diet Doc Contact Information:

San Diego, CA
(800) 272-0482
Weight-loss(at)Dietdoc(dot)info
http://doctorsupervisedweightloss.com/how-it-works.php

Twitter: DietDoc10
Facebook: DietDochcg

Alyssa Gojmerac, Dietdoc.co, http://doctorsupervisedweightloss.com/, 800-272-0482, [email protected]

Modal title

Before and after weight loss
Before and after weight loss
Before and after weight loss

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.